TreeWAS – Variant ID: rs16870629

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
A49.8 Other bacterial infections of unspecified site	0.160	0.840	0.000
A49 Bacterial infection of unspecified site	0.159	0.841	0.000
A49.9 Bacterial infection, unspecified	0.150	0.850	0.000
A41 Other septicaemia	0.150	0.850	0.000
A30-A49 Other bacterial diseases	0.148	0.852	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.148	0.852	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.134	0.866	0.000
A48 Other bacterial diseases, not elsewhere classified	0.131	0.869	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.127	0.873	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.124	0.876	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.121	0.879	0.000
A49.3 Mycoplasma infection, unspecified	0.114	0.886	0.000
A48.3 Toxic shock syndrome	0.111	0.889	0.000
A49.1 Streptococcal infection, unspecified	0.110	0.890	0.000
A48.8 Other specified bacterial diseases	0.108	0.892	0.000
A41.4 Septicaemia due to anaerobes	0.107	0.893	0.000
A41.3 Septicaemia due to Haemophilus influenzae	0.107	0.893	0.000
A46 Erysipelas	0.107	0.893	0.000
A44 Bartonellosis	0.107	0.893	0.000
A43 Nocardiosis	0.107	0.893	0.000
A37 Whooping cough	0.107	0.893	0.000
A36 Diphtheria	0.107	0.893	0.000
A32 Listeriosis	0.107	0.893	0.000
A30 Leprosy [Hansen's disease]	0.107	0.893	0.000
A38 Scarlet fever	0.107	0.893	0.000
A35 Other tetanus	0.107	0.893	0.000
A34 Obstetrical tetanus	0.107	0.893	0.000
A33 Tetanus neonatorum	0.107	0.893	0.000
A42 Actinomycosis	0.106	0.894	0.000
A39 Meningococcal infection	0.101	0.899	0.000
A48.1 Legionnaires' disease	0.096	0.904	0.000
A48.4 Brazilian purpuric fever	0.094	0.906	0.000
A48.2 Nonpneumonic Legionnaires' disease [Pontiac fever]	0.094	0.906	0.000
A48.0 Gas gangrene	0.094	0.906	0.000
A41.9 Septicaemia, unspecified	0.093	0.907	0.000
A41.8 Other specified septicaemia	0.091	0.909	0.000
A31 Infection due to other mycobacteria	0.091	0.909	0.000
A49.0 Staphylococcal infection, unspecified	0.087	0.913	0.000
A39.0 Meningococcal meningitis	0.080	0.920	0.000
A40 Streptococcal septicaemia	0.079	0.920	0.000
A30.9 Leprosy, unspecified	0.077	0.923	0.000
A30.8 Other forms of leprosy	0.077	0.923	0.000
A30.5 Lepromatous leprosy	0.077	0.923	0.000
A30.4 Borderline lepromatous leprosy	0.077	0.923	0.000
A30.3 Borderline leprosy	0.077	0.923	0.000
A30.2 Borderline tuberculoid leprosy	0.077	0.923	0.000
A30.1 Tuberculoid leprosy	0.077	0.923	0.000
A30.0 Indeterminate leprosy	0.077	0.923	0.000
A32.9 Listeriosis, unspecified	0.077	0.923	0.000
A32.8 Other forms of listeriosis	0.077	0.923	0.000
A32.7 Listerial septicaemia	0.077	0.923	0.000
A32.1 Listerial meningitis and meningoencephalitis	0.077	0.923	0.000
A32.0 Cutaneous listeriosis	0.077	0.923	0.000
A36.9 Diphtheria, unspecified	0.077	0.923	0.000
A36.8 Other diphtheria	0.077	0.923	0.000
A36.3 Cutaneous diphtheria	0.077	0.923	0.000
A36.2 Laryngeal diphtheria	0.077	0.923	0.000
A36.1 Nasopharyngeal diphtheria	0.077	0.923	0.000
A36.0 Pharyngeal diphtheria	0.077	0.923	0.000
A37.9 Whooping cough, unspecified	0.077	0.923	0.000
A37.8 Whooping cough due to other Bordetella species	0.077	0.923	0.000
A37.1 Whooping cough due to Bordetella parapertussis	0.077	0.923	0.000
A37.0 Whooping cough due to Bordetella pertussis	0.077	0.923	0.000
A43.9 Nocardiosis, unspecified	0.077	0.923	0.000
A43.8 Other forms of nocardiosis	0.077	0.923	0.000
A43.1 Cutaneous nocardiosis	0.077	0.923	0.000
A43.0 Pulmonary nocardiosis	0.077	0.923	0.000
A44.9 Bartonellosis, unspecified	0.077	0.923	0.000
A44.8 Other forms of bartonellosis	0.077	0.923	0.000
A44.1 Cutaneous and mucocutaneous bartonellosis	0.077	0.923	0.000
A44.0 Systemic bartonellosis	0.077	0.923	0.000
A42.9 Actinomycosis, unspecified	0.076	0.924	0.000
A42.7 Actinomycotic septicaemia	0.076	0.924	0.000
A42.2 Cervicofacial actinomycosis	0.076	0.924	0.000
A42.1 Abdominal actinomycosis	0.076	0.924	0.000
A42.0 Pulmonary actinomycosis	0.076	0.924	0.000
A42.8 Other forms of actinomycosis	0.075	0.924	0.000
A39.9 Meningococcal infection, unspecified	0.072	0.927	0.000
A39.8 Other meningococcal infections	0.072	0.927	0.000
A39.5 Meningococcal heart disease	0.072	0.927	0.000
A39.3 Chronic meningococcaemia	0.072	0.927	0.000
A39.2 Acute meningococcaemia	0.072	0.927	0.000
A39.1 Waterhouse-Friderichsen syndrome	0.072	0.927	0.000
A40.0 Septicaemia due to streptococcus, group A	0.068	0.932	0.000
A31.8 Other mycobacterial infections	0.065	0.935	0.000
A31.1 Cutaneous mycobacterial infection	0.065	0.935	0.000
A31.9 Mycobacterial infection, unspecified	0.058	0.941	0.000
A31.0 Pulmonary mycobacterial infection	0.058	0.942	0.000
A40.2 Septicaemia due to streptococcus, group D	0.057	0.943	0.000
A40.9 Streptococcal septicaemia, unspecified	0.055	0.944	0.000
A39.4 Meningococcaemia, unspecified	0.055	0.945	0.000
A40.1 Septicaemia due to streptococcus, group B	0.053	0.947	0.000
A40.3 Septicaemia due to Streptococcus pneumoniae	0.039	0.961	0.000
A40.8 Other streptococcal septicaemia	0.037	0.963	0.000
C73 Malignant neoplasm of thyroid gland	0.000	0.982	0.018
G70.0 Myasthenia gravis	0.000	0.985	0.015
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.986	0.014
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.000	0.990	0.010
I50.9 Heart failure, unspecified	0.009	0.991	0.000
C74 Malignant neoplasm of adrenal gland	0.000	0.991	0.009
G70 Myasthenia gravis and other myoneural disorders	0.000	0.991	0.008
I50.1 Left ventricular failure	0.009	0.991	0.000
I50 Heart failure	0.009	0.991	0.000
C74.9 Adrenal gland, unspecified	0.000	0.992	0.008
I50.0 Congestive heart failure	0.008	0.992	0.000
G70.9 Myoneural disorder, unspecified	0.000	0.993	0.007
C75 Malignant neoplasm of other endocrine glands and related structures	0.000	0.993	0.007
U80.0 Penicillin resistant agent	0.007	0.993	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.993	0.007
M47.96 Spondylosis, unspecified (Lumbar region)	0.007	0.993	0.000
C74.1 Medulla of adrenal gland	0.000	0.993	0.006
C74.0 Cortex of adrenal gland	0.000	0.993	0.006
M50.3 Other cervical disk degeneration	0.000	0.993	0.007
G70.8 Other specified myoneural disorders	0.000	0.994	0.006
G70.2 Congenital and developmental myasthenia	0.000	0.994	0.006
G70.1 Toxic myoneural disorders	0.000	0.994	0.006
B18.1 Chronic viral hepatitis B without delta-agent	0.006	0.994	0.000
T45.5 Anticoagulants	0.000	0.994	0.006
B18.2 Chronic viral hepatitis C	0.006	0.994	0.000
U80 Agent resistant to penicillin and related antibiotics	0.006	0.994	0.000
B18 Chronic viral hepatitis	0.006	0.994	0.000
C75.9 Endocrine gland, unspecified	0.000	0.995	0.005
C75.8 Pluriglandular involvement, unspecified	0.000	0.995	0.005
C75.5 Aortic body and other paraganglia	0.000	0.995	0.005
C75.4 Carotid body	0.000	0.995	0.005
C75.3 Pineal gland	0.000	0.995	0.005
C75.2 Craniopharyngeal duct	0.000	0.995	0.005
C75.1 Pituitary gland	0.000	0.995	0.005
U80.1 Methicillin resistant agent	0.005	0.995	0.000
C75.0 Parathyroid gland	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
U80.8 Agent resistant to other penicillin-related antibiotic	0.005	0.995	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.995	0.005
Z43.1 Attention to gastrostomy	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.995	0.005
C53.9 Cervix uteri, unspecified	0.000	0.995	0.005
D06.9 Cervix, unspecified	0.005	0.995	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.005	0.995	0.000
S30.1 Contusion of abdominal wall	0.005	0.995	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.995	0.005
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.996	0.004
Z96.7 Presence of other bone and tendon implants	0.004	0.996	0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.004	0.996	0.000
X51.9 Unspecified place	0.004	0.996	0.000
Q21.1 Atrial septal defect	0.004	0.996	0.000
B18.9 Chronic viral hepatitis, unspecified	0.004	0.996	0.000
B18.8 Other chronic viral hepatitis	0.004	0.996	0.000
B18.0 Chronic viral hepatitis B with delta-agent	0.004	0.996	0.000
J32 Chronic sinusitis	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
B15-B19 Viral hepatitis	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
J32.2 Chronic ethmoidal sinusitis	0.000	0.996	0.004
S30 Superficial injury of abdomen, lower back and pelvis	0.004	0.996	0.000
B16 Acute hepatitis B	0.004	0.996	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
E04 Other non-toxic goitre	0.000	0.996	0.004
J32.8 Other chronic sinusitis	0.000	0.996	0.004
X51 Travel and motion	0.004	0.996	0.000
E04.0 Non-toxic diffuse goitre	0.000	0.996	0.004
C83.1 Small cleaved cell (diffuse)	0.004	0.996	0.000
C83.3 Large cell (diffuse)	0.004	0.996	0.000
X50.4 Street and highway	0.004	0.996	0.000
J32.1 Chronic frontal sinusitis	0.000	0.996	0.004
T42.4 Benzodiazepines	0.000	0.996	0.004
X50 Overexertion and strenuous or repetitive movements	0.004	0.996	0.000
D37.4 Colon	0.004	0.996	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
J38.1 Polyp of vocal cord and larynx	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.996	0.004
C83 Diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
J32.3 Chronic sphenoidal sinusitis	0.000	0.997	0.003
X51.8 Other specified place	0.003	0.997	0.000
B17 Other acute viral hepatitis	0.003	0.997	0.000
E78.8 Other disorders of lipoprotein metabolism	0.003	0.997	0.000
M25.47 Effusion of joint (Ankle and foot)	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
K04.5 Chronic apical periodontitis	0.000	0.997	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.003	0.997	0.000
J32.4 Chronic pansinusitis	0.000	0.997	0.003
X50.6 Industrial and construction area	0.003	0.997	0.000
X50.2 School, other institution and public administrative area	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.003	0.997	0.000
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.003	0.997	0.000
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.003	0.997	0.000
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.003	0.997	0.000
S30.2 Contusion of external genital organs	0.003	0.997	0.000
B17.2 Acute hepatitis E	0.003	0.997	0.000
E04.8 Other specified non-toxic goitre	0.000	0.997	0.003
B15 Acute hepatitis A	0.003	0.997	0.000
X50-X57 Overexertion, travel and privation	0.003	0.997	0.000
X51.7 Farm	0.003	0.997	0.000
X51.6 Industrial and construction area	0.003	0.997	0.000
X51.5 Trade and service area	0.003	0.997	0.000
X51.4 Street and highway	0.003	0.997	0.000
X51.3 Sports and athletics area	0.003	0.997	0.000
X51.2 School, other institution and public administrative area	0.003	0.997	0.000
X51.1 Residential institution	0.003	0.997	0.000
X51.0 Home	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.003	0.997	0.000
B17.8 Other specified acute viral hepatitis	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
X50.9 Unspecified place	0.003	0.997	0.000
X50.8 Other specified place	0.003	0.997	0.000
X50.5 Trade and service area	0.003	0.997	0.000
X50.3 Sports and athletics area	0.003	0.997	0.000
X50.0 Home	0.003	0.997	0.000
X50.7 Farm	0.003	0.997	0.000
X50.1 Residential institution	0.003	0.997	0.000
B19 Unspecified viral hepatitis	0.003	0.997	0.000
R16.1 Splenomegaly, not elsewhere classified	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.000	0.997	0.003
R16.0 Hepatomegaly, not elsewhere classified	0.003	0.997	0.000
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.003	0.997	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
K29.3 Chronic superficial gastritis	0.000	0.997	0.003
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
C85.0 Lymphosarcoma	0.003	0.997	0.000
J40 Bronchitis, not specified as acute or chronic	0.000	0.997	0.003
M94.86 Other specified disorders of cartilage (Lower leg)	0.003	0.997	0.000
B17.9 Acute viral hepatitis, unspecified	0.002	0.997	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.002
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.002	0.997	0.000
C82.2 Large cell, follicular	0.002	0.997	0.000
Q18.0 Sinus, fistula and cyst of branchial cleft	0.003	0.997	0.000
T42.3 Barbiturates	0.000	0.997	0.002
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.997	0.000
S32.40 Fracture of acetabulum (closed)	0.002	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.997	0.000
C53 Malignant neoplasm of cervix uteri	0.000	0.997	0.002
B15.0 Hepatitis A with hepatic coma	0.002	0.998	0.000
X57 Unspecified privation	0.002	0.998	0.000
X54 Lack of water	0.002	0.998	0.000
X53 Lack of food	0.002	0.998	0.000
X52 Prolonged stay in weightless environment	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
C83.0 Small cell (diffuse)	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
I46.0 Cardiac arrest with successful resuscitation	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.998	0.000
H04 Disorders of lachrymal system	0.000	0.998	0.002
X50.09 Overexertion and strenuous or repetitive movements; Home; During unspecified activity	0.002	0.998	0.000
X50.04 Overexertion and strenuous or repetitive movements; Home; While resting, sleeping, eating or engaging in other vital activities	0.002	0.998	0.000
X50.30 Overexertion and strenuous or repetitive movements; Sports and athletics area;While engaged in sports activity	0.002	0.998	0.000
X50.52 Overexertion and strenuous or repetitive movements, Trade and service area, While working for income	0.002	0.998	0.000
X50.89 Overexertion and strenuous or repetitive movements: Other specified places: During unspecified activity	0.002	0.998	0.000
X50.82 Overexertion and strenuous or repetitive movements; Other specified places ;While working for income	0.002	0.998	0.000
X50.99 Overexertion and strenuous or repetitive movements; Unspecified place ;During unspecified activity	0.002	0.998	0.000
X50.90 Overexertion and strenuous or repetitive movements: Unspecified place: While engaged in sports activity	0.002	0.998	0.000
H16.9 Keratitis, unspecified	0.002	0.998	0.000
Chapter I Certain infectious and parasitic diseases	0.002	0.998	0.000
B19.0 Unspecified viral hepatitis with coma	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
W19.4 Street and highway	0.000	0.998	0.002
B17.1 Acute hepatitis C	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.998	0.002
H02.0 Entropion and trichiasis of eyelid	0.000	0.998	0.002
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.000	0.998	0.002
G93.1 Anoxic brain damage, not elsewhere classified	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.002	0.998	0.000
B15.9 Hepatitis A without hepatic coma	0.002	0.998	0.000
C53.0 Endocervix	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.002	0.998	0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.002	0.998	0.000
S32.4 Fracture of acetabulum	0.002	0.998	0.000
A86 Unspecified viral encephalitis	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
H16 Keratitis	0.002	0.998	0.000
C94.4 Acute panmyelosis	0.002	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
C94.7 Other specified leukaemias	0.002	0.998	0.000
C94.5 Acute myelofibrosis	0.002	0.998	0.000
C94.3 Mast cell leukaemia	0.002	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.998	0.000
C94.1 Chronic erythraemia	0.002	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.998	0.000
D30.3 Bladder	0.002	0.998	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.000	0.998	0.002
A80-A89 Viral infections of the central nervous system	0.002	0.998	0.000
H16.8 Other keratitis	0.002	0.998	0.000
J46 Status asthmaticus	0.000	0.998	0.002
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
C53.8 Overlapping lesion of cervix uteri	0.000	0.998	0.002
C53.1 Exocervix	0.000	0.998	0.002
X52.9 Unspecified place	0.002	0.998	0.000
X52.8 Other specified place	0.002	0.998	0.000
X52.7 Farm	0.002	0.998	0.000
X52.6 Industrial and construction area	0.002	0.998	0.000
X52.5 Trade and service area	0.002	0.998	0.000
X52.4 Street and highway	0.002	0.998	0.000
X52.3 Sports and athletics area	0.002	0.998	0.000
X52.2 School, other institution and public administrative area	0.002	0.998	0.000
X52.1 Residential institution	0.002	0.998	0.000
X52.0 Home	0.002	0.998	0.000
X53.9 Unspecified place	0.002	0.998	0.000
X53.8 Other specified place	0.002	0.998	0.000
X53.7 Farm	0.002	0.998	0.000
X53.6 Industrial and construction area	0.002	0.998	0.000
X53.5 Trade and service area	0.002	0.998	0.000
X53.4 Street and highway	0.002	0.998	0.000
X53.3 Sports and athletics area	0.002	0.998	0.000
X53.2 School, other institution and public administrative area	0.002	0.998	0.000
X53.1 Residential institution	0.002	0.998	0.000
X53.0 Home	0.002	0.998	0.000
X54.9 Unspecified place	0.002	0.998	0.000
X54.8 Other specified place	0.002	0.998	0.000
X54.7 Farm	0.002	0.998	0.000
X54.6 Industrial and construction area	0.002	0.998	0.000
X54.5 Trade and service area	0.002	0.998	0.000
X54.4 Street and highway	0.002	0.998	0.000
X54.3 Sports and athletics area	0.002	0.998	0.000
X54.2 School, other institution and public administrative area	0.002	0.998	0.000
X54.1 Residential institution	0.002	0.998	0.000
X54.0 Home	0.002	0.998	0.000
X57.9 Unspecified place	0.002	0.998	0.000
X57.8 Other specified place	0.002	0.998	0.000
X57.7 Farm	0.002	0.998	0.000
X57.6 Industrial and construction area	0.002	0.998	0.000
X57.5 Trade and service area	0.002	0.998	0.000
X57.4 Street and highway	0.002	0.998	0.000
X57.3 Sports and athletics area	0.002	0.998	0.000
X57.2 School, other institution and public administrative area	0.002	0.998	0.000
X57.1 Residential institution	0.002	0.998	0.000
X57.0 Home	0.002	0.998	0.000
A20-A28 Certain zoonotic bacterial diseases	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.002	0.998	0.000
I05.0 Mitral stenosis	0.002	0.998	0.000
S30.0 Contusion of lower back and pelvis	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.000	0.998	0.002
B85-B89 Pediculosis, acariasis and other infestations	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
T42.1 Iminostilbenes	0.000	0.998	0.002
B65-B83 Helminthiases	0.002	0.998	0.000
S33.5 Sprain and strain of lumbar spine	0.002	0.998	0.000
S33.2 Dislocation of sacro-iliac and sacrococcygeal joint	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
M66.47 Spontaneous rupture of other tendons (Ankle and foot)	0.002	0.998	0.000
H04.9 Disorder of lachrymal system, unspecified	0.000	0.998	0.002
H04.0 Dacryoadenitis	0.000	0.998	0.002
S36.00 Injury of spleen (without open wound into cavity)	0.002	0.998	0.000
B19.9 Unspecified viral hepatitis without coma	0.002	0.998	0.000
F43.2 Adjustment disorders	0.000	0.998	0.002
J33.8 Other polyp of sinus	0.000	0.998	0.002
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.002	0.998	0.000
A75-A79 Rickettsioses	0.002	0.998	0.000
A70-A74 Other diseases caused by chlamydiae	0.002	0.998	0.000
S36 Injury of intra-abdominal organs	0.002	0.998	0.000
H16.4 Corneal neovascularisation	0.002	0.998	0.000
S36.0 Injury of spleen	0.002	0.998	0.000
D06 Carcinoma in situ of cervix uteri	0.002	0.998	0.000
J20.9 Acute bronchitis, unspecified	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.002	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.002	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.002	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.002	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.002	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.002	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
C96.8 Histiocytic sarcoma	0.002	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.998	0.000
C96.3 True histiocytic lymphoma	0.002	0.998	0.000
C96.2 Malignant mast cell tumour	0.002	0.998	0.000
C96.1 Malignant histiocytosis	0.002	0.998	0.000
C96.0 Letterer-Siwe disease	0.002	0.998	0.000
S31 Open wound of abdomen, lower back and pelvis	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
H04.8 Other disorders of lachrymal system	0.000	0.998	0.002
S37 Injury of urinary and pelvic organs	0.002	0.998	0.000
H16.2 Keratoconjunctivitis	0.002	0.998	0.000
S33.1 Dislocation of lumbar vertebra	0.002	0.998	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.000	0.998	0.002
Z93.1 Gastrostomy status	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
S32 Fracture of lumbar spine and pelvis	0.002	0.998	0.000
A65-A69 Other spirochaetal diseases	0.002	0.998	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
C93.9 Monocytic leukaemia, unspecified	0.002	0.998	0.000
C93.7 Other monocytic leukaemia	0.002	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.998	0.000
C93.0 Acute monocytic leukaemia	0.002	0.998	0.000
A27 Leptospirosis	0.002	0.998	0.000
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
S33.7 Sprain and strain of other and unspecified parts of lumbar spine and pelvis	0.002	0.998	0.000
S33.6 Sprain and strain of sacro-iliac joint	0.002	0.998	0.000
S33.4 Traumatic rupture of symphysis pubis	0.002	0.998	0.000
S33.3 Dislocation of other and unspecified parts of lumbar spine and pelvis	0.002	0.998	0.000
S33.0 Traumatic rupture of lumbar intervertebral disk	0.002	0.998	0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.002	0.998	0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.002	0.998	0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.002	0.998	0.000
S32.41 Fracture of acetabulum (open)	0.002	0.998	0.000
H04.6 Other changes in lachrymal passages	0.000	0.998	0.002
H18.3 Changes in corneal membranes	0.002	0.998	0.000
S01.5 Open wound of lip and oral cavity	0.000	0.998	0.002
Z81.8 Family history of other mental and behavioural disorders	0.000	0.998	0.002
B86 Scabies	0.002	0.998	0.000
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.002	0.998	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.002	0.998	0.000
Z29.8 Other specified prophylactic measures	0.002	0.998	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.002	0.998	0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.002	0.998	0.000
A88 Other viral infections of central nervous system, not elsewhere classified	0.002	0.998	0.000
A85 Other viral encephalitis, not elsewhere classified	0.002	0.998	0.000
A84 Tick-borne viral encephalitis	0.002	0.998	0.000
A83 Mosquito-borne viral encephalitis	0.002	0.998	0.000
A82 Rabies	0.002	0.998	0.000
A91 Dengue haemorrhagic fever	0.002	0.998	0.000
A90 Dengue fever [classical dengue]	0.002	0.998	0.000
A89 Unspecified viral infection of central nervous system	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
M89 Other disorders of bone	0.002	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.998	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.002	0.998	0.000
T36.0 Penicillins	0.000	0.998	0.002
A28 Other zoonotic bacterial diseases, not elsewhere classified	0.002	0.998	0.000
A26 Erysipeloid	0.002	0.998	0.000
A25 Rat-bite fevers	0.002	0.998	0.000
A24 Glanders and melioidosis	0.002	0.998	0.000
A23 Brucellosis	0.002	0.998	0.000
A22 Anthrax	0.002	0.998	0.000
A21 Tularaemia	0.002	0.998	0.000
A20 Plague	0.002	0.998	0.000
A80 Acute poliomyelitis	0.001	0.998	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations